Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Financing Activities: 2010-2025

Historic Cash from Financing Activities for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to $3.2 million.

  • SRx Health Solutions' Cash from Financing Activities fell 1788.6% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.9 million, marking a year-over-year increase of 3482.73%. This contributed to the annual value of -$5.1 million for FY2023, which is 49758.19% down from last year.
  • Per SRx Health Solutions' latest filing, its Cash from Financing Activities stood at $3.2 million for Q2 2025, which was down 1788.6% from -$1.2 million recorded in Q1 2025.
  • SRx Health Solutions' Cash from Financing Activities' 5-year high stood at $34.4 million during Q3 2021, with a 5-year trough of -$4.6 million in Q2 2023.
  • In the last 5 years, SRx Health Solutions' Cash from Financing Activities had a median value of -$41000.0 in 2023 and averaged $2.6 million.
  • Per our database at Business Quant, SRx Health Solutions' Cash from Financing Activities plummeted by 193466.67% in 2023 and then skyrocketed by 350933.33% in 2024.
  • Over the past 5 years, SRx Health Solutions' Cash from Financing Activities (Quarter) stood at -$552000.0 in 2021, then dropped by 1.63% to -$561000.0 in 2022, then soared by 41.53% to -$328000.0 in 2023, then surged by 1659.15% to $5.1 million in 2024, then plummeted by 38.33% to $3.2 million in 2025.
  • Its Cash from Financing Activities was $3.2 million in Q2 2025, compared to -$1.2 million in Q1 2025 and $5.1 million in Q3 2024.